• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reimagining Global Oncology Clinical Trials for the Postpandemic Era: A Call to Arms.

作者信息

Saini Kamal S, de Las Heras Begoña, Plummer Ruth, Moreno Victor, Romano Marco, de Castro Javier, Aftimos Philippe, Fredriksson Judy, Bhattacharyya Gouri Shankar, Olivo Martin Sebastian, Schiavon Gaia, Punie Kevin, Garcia-Foncillas Jesus, Rogata Ernesto, Pfeiffer Richie, Orbegoso Cecilia, Morrison Kenneth, Curigliano Giuseppe, Chin Lynda, Saini Monika Lamba, Rekdal Øystein, Anderson Steven, Cortes Javier, Leone Manuela, Dancey Janet, Twelves Chris, Awada Ahmad

机构信息

Covance, Princeton, NJ.

East Suffolk and North Essex NHS Foundation Trust, Ipswich, United Kingdom.

出版信息

JCO Glob Oncol. 2020 Sep;6:1357-1362. doi: 10.1200/GO.20.00346.

DOI:10.1200/GO.20.00346
PMID:32897732
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7529519/
Abstract
摘要

相似文献

1
Reimagining Global Oncology Clinical Trials for the Postpandemic Era: A Call to Arms.重塑大流行后时代的全球肿瘤学临床试验：战斗的号角。
JCO Glob Oncol. 2020 Sep;6:1357-1362. doi: 10.1200/GO.20.00346.
2
Reimagining Cancer Staging in the Era of Evolutionary Oncology.重新构想进化肿瘤学时代的癌症分期
J Natl Compr Canc Netw. 2022 Dec;20(12):1370-1372. doi: 10.6004/jnccn.2022.7078.
3
Letter to the Editor: Re: Reimagining Cancer Staging in the Era of Evolutionary Oncology.致编辑的信：关于：在进化肿瘤学时代重新构想癌症分期。
J Natl Compr Canc Netw. 2023 Apr;21(4):xviii. doi: 10.6004/jnccn.2023.7012.
4
Virtual Tumor Board: Benefits, Problems, and Finding Balance in a Postpandemic Future.虚拟肿瘤讨论会：在后疫情时代的未来中的益处、问题及寻求平衡
JCO Oncol Pract. 2022 Oct;18(10):691-693. doi: 10.1200/OP.22.00503. Epub 2022 Sep 1.
5
Reimagining cancer care delivery-and serving employers-through Access Hope.通过“Access Hope”重新构想癌症护理服务——并为雇主提供服务。
Am J Manag Care. 2020 Dec;26(10 Spec No.):SP365-SP366. doi: 10.37765/ajmc.2020.88558.
6
The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017).个性化医学和肿瘤免疫时代临床试验的变化：国际肿瘤学和血液肿瘤学临床试验大会（ICTO 2017）报告。
J Exp Clin Cancer Res. 2017 Dec 28;36(1):192. doi: 10.1186/s13046-017-0668-0.
7
Ethical considerations of neuro-oncology trial design in the era of precision medicine.精准医学时代神经肿瘤学试验设计的伦理考量
J Neurooncol. 2017 Aug;134(1):1-7. doi: 10.1007/s11060-017-2502-0. Epub 2017 May 29.
8
New molecular oncology-changing era: prospects and challenges of cancer genome and integrative systems biology.新分子肿瘤学——变革的时代：癌症基因组与整合系统生物学的前景与挑战
Expert Rev Anticancer Ther. 2011 Jan;11(1):5-8. doi: 10.1586/era.10.176.
9
Clinical trials in the era of personalized oncology.个体化肿瘤学时代的临床试验。
CA Cancer J Clin. 2011 Nov-Dec;61(6):365-81. doi: 10.3322/caac.20135. Epub 2011 Oct 27.
10
Clinical Evidence Generation During a Pandemic: Lessons Learned for Sustaining Progress.大流行期间的临床证据生成：持续进展的经验教训。
Cancer J. 2022;28(2):151-156. doi: 10.1097/PPO.0000000000000589.

引用本文的文献

1
External control arms: COVID-19 reveals the merits of using real world evidence in real-time for clinical and public health investigations.外部对照臂：新冠疫情揭示了在临床和公共卫生调查中实时使用真实世界证据的优点。
Front Med (Lausanne). 2023 Jul 6;10:1198088. doi: 10.3389/fmed.2023.1198088. eCollection 2023.
2
Quantifying the impact of the COVID-19 pandemic on clinical trial screening rates over time in 37 countries.定量分析 COVID-19 大流行对 37 个国家临床试验筛选率随时间变化的影响。
Trials. 2023 Apr 4;24(1):254. doi: 10.1186/s13063-023-07277-1.
3
Decentralized clinical trials (DCTs): A few ethical considerations.去中心化临床试验（DCTs）：几点伦理考虑。
Front Public Health. 2022 Dec 15;10:1081150. doi: 10.3389/fpubh.2022.1081150. eCollection 2022.
4
Thinking globally to improve care locally: A Delphi study protocol to achieve international clinical consensus on best-practice end-of-life communication with adolescents and young adults with cancer.全球化思考，本地化改善照护：一项德尔菲研究方案，旨在就癌症晚期青少年和年轻患者最佳实践临终沟通达成国际临床共识。
PLoS One. 2022 Jul 8;17(7):e0270797. doi: 10.1371/journal.pone.0270797. eCollection 2022.
5
Role of decentralized clinical trials in cancer drug development: Results from a survey of oncologists and patients.去中心化临床试验在癌症药物研发中的作用：肿瘤学家和患者调查结果
Digit Health. 2022 May 25;8:20552076221099997. doi: 10.1177/20552076221099997. eCollection 2022 Jan-Dec.
6
Report from the Ready for the Next Round Thought-Leadership Roundtables on Building Resilience in Cancer Care and Control in Canada-Colorectal Cancer Canada; 2021.加拿大癌症控制与康复研究学会（加拿大结直肠癌学会）下一轮思维领导力圆桌会议报告：打造癌症防治韧性
Curr Oncol. 2022 Mar 7;29(3):1723-1743. doi: 10.3390/curroncol29030143.
7
Eligibility Criteria Perpetuate Disparities in Enrollment and Participation of Black Patients in Pancreatic Cancer Clinical Trials.入选标准使黑人患者在胰腺癌临床试验中的入组和参与存在差异。
J Clin Oncol. 2022 Jul 10;40(20):2193-2202. doi: 10.1200/JCO.21.02492. Epub 2022 Mar 22.
8
Emerging issues related to COVID-19 vaccination in patients with cancer.癌症患者中与新冠病毒疫苗接种相关的新出现问题。
Oncol Ther. 2021 Dec;9(2):255-265. doi: 10.1007/s40487-021-00157-1. Epub 2021 Jun 16.
9
COVID-19 and Global Oncology: A Year in Review.《2019冠状病毒病与全球肿瘤学：年度回顾》
JCO Glob Oncol. 2021 May;7:797-801. doi: 10.1200/GO.21.00078.
10
Managing children with brain tumors during the COVID-19 era: Don't stop the care!在新冠疫情时代管理患有脑肿瘤的儿童：不要停止护理！
Comput Struct Biotechnol J. 2021 Jan 12;19:705-709. doi: 10.1016/j.csbj.2021.01.005. eCollection 2021.

本文引用的文献

1
Rethinking cancer clinical trials for COVID-19 and beyond.重新思考癌症临床试验在 COVID-19 及以后的应用。
Nat Cancer. 2020 Jun;1(6):568-572. doi: 10.1038/s43018-020-0083-x.
2
Covid-19 Pandemic-An Opportunity to Reduce and Eliminate Low-Value Practices in Oncology?新冠疫情——减少和消除肿瘤学中低价值医疗行为的契机？
JAMA Oncol. 2020 Nov 1;6(11):1693-1694. doi: 10.1001/jamaoncol.2020.2404.
3
Increased vulnerability of clinical research units during the COVID-19 crisis and their protection.在 COVID-19 危机期间增加临床研究单位的脆弱性及其保护。
Cancer. 2020 Sep 1;126(17):3907-3911. doi: 10.1002/cncr.32980. Epub 2020 Jun 2.
4
Association of the Coronavirus Disease 2019 (COVID-19) Outbreak With Enrollment in Cancer Clinical Trials.新型冠状病毒病 2019（COVID-19）疫情与癌症临床试验入组的相关性。
JAMA Netw Open. 2020 Jun 1;3(6):e2010651. doi: 10.1001/jamanetworkopen.2020.10651.
5
Implications for Telehealth in a Postpandemic Future: Regulatory and Privacy Issues.疫情后时代远程医疗的影响：监管与隐私问题
JAMA. 2020 Jun 16;323(23):2375-2376. doi: 10.1001/jama.2020.7943.
6
Cancer Research after COVID-19: Where Do We Go from Here?新冠疫情后的癌症研究：我们将何去何从？
Cancer Cell. 2020 May 11;37(5):637-638. doi: 10.1016/j.ccell.2020.04.003.
7
Early Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-Term Opportunities for Transformation: Findings From an American Society of Clinical Oncology Survey.COVID-19 对肿瘤学临床试验开展的早期影响及长期变革机遇：美国临床肿瘤学会调查研究结果。
JCO Oncol Pract. 2020 Jul;16(7):417-421. doi: 10.1200/OP.20.00275. Epub 2020 May 12.
8
ESMO Clinical Research Observatory (ECRO): improving the efficiency of clinical research through rationalisation of bureaucracy.ESMO 临床研究观察站（ECRO）：通过精简官僚主义提高临床研究效率。
ESMO Open. 2020 May;5(3):e000662. doi: 10.1136/esmoopen-2019-000662.
9
Understanding Verbosity: Funding Source and the Length of Consent Forms for Cancer Clinical Trials.理解冗长：癌症临床试验的经费来源与知情同意书长度。
J Cancer Educ. 2021 Dec;36(6):1248-1252. doi: 10.1007/s13187-020-01757-7.
10
Effect of the COVID-19 pandemic on cancer treatment and research.2019冠状病毒病大流行对癌症治疗及研究的影响。
Lancet Haematol. 2020 Jun;7(6):e432-e435. doi: 10.1016/S2352-3026(20)30123-X. Epub 2020 Apr 24.